Awareness and uptake of human papillomavirus vaccines among female undergraduate students: Implications for cervical cancer prevention in South‑South, Nigeria
Article Sidebar
Main Article Content
Abstract
Background: Human papillomavirus(HPV) is a sexually transmitted infection found most commonly among sexually active adolescents and young women. HPV vaccine is available in Nigeria. However, very few persons have been vaccinated. This study, therefore, aimed to assess the level of awareness of HPV infection and its vaccine uptake among female university students in Rivers State.
Methods: This was a descriptive cross-sectional study carried out between July and October 2015 in three Universities in Rivers State, Nigeria. Multistage sampling was used to identify the study participants.
Results: A total of 780 eligible females were recruited into the study. About 262 (33.6%) had heard of HPV infection and 203 (26%) had heard of HPV vaccines. Among those who had heard of HPV vaccines, 148 (72.9%) were aware that the vaccine could protect against HPV infection while 97 (47.8%) were aware that the vaccine could protect against cervical cancer. Only 40 (5.1%) of study participants had been vaccinated with HPV vaccine. HPV vaccine uptake was significantly predicted by respondent’s marital status (adjusted OR [AdjOR] = 0.061; 0.015–0.246), parity (AdjOR = 5.855; 1.433–23.923) and knowledge about HPV (AdjOR = 7.918; 3.062–20.475).
Conclusion: Awareness of HPV infection and HPV vaccine among female undergraduates in Rivers State is poor. There is, therefore, need for health promotion interventions that address this gap as part of cervical cancer control activities.
Downloads
Article Details
The journal grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License.
References
1. Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003;12:485‑90.
2. Dahlstrom LA, Tran TN, Lundholm C, Young C, Sundstrom K, Sparen P. Attitude to HPV vaccination among parents of children aged 12‑15 years – A population‑based survey in Sweden. Int J Cancer 2010;26:500‑7.
3. WHO. Human Papillomavirus (HPV) and Cervical Cancer. Available from: http://www.who.int/mediacentre/factsheets/fs380/en/. [Last reviewed on 2015 Mar 25].
4. Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: Knowledge, attitudes, and behavior
intervention in adolescents and young women in Italy. Br J Cancer 2008;99:225‑9.
5. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12‑9.
6. Odetola TD, Ekpo K. Nigerian women’s perceptions about human papilloma virus immunization. J Community Med Health Educ 2012;2:191.
7. Cummins J, Mae‑Wan H. The HPV vaccine controversy. Sci Soc 2009;42:15‑20.
8. Haug CJ. Human papillomavirus vaccination – A reason for caution. N Engl J Med 2008;59:861‑2.
9. Akanbi OA, Iyanda A, Osundare F, Opaleye OO. Perceptions of Nigerian Women about Human Papilloma Virus, Cervical Cancer, and HPV Vaccine. Scientifica 2015; 285702:4.
10. Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, et al. Effect of human papillomavirus 16/18 L1 virus like particle vaccine among young women with preexisting infection: A randomized trial. JAMA 2007;298:743‑53.
11. Ezenwa BN, Balogun MR, OkaforIP. Mothers’ human papilloma virus knowledge and willingness to vaccinate their adolescent daughters in
Lagos, Nigeria. Int J Womens Health 2013;5:371‑7.
12. Hoque ME, Ghuman S, Hal GV. Human papillomavirus vaccination acceptability among female university students in South Africa. Asian Pac J Cancer Prev 2013;14:4865‑9.
13. Rivers State Government Website. Available from: http://www.riversstate.gov.ng/. [Last retrieved on 2010 Dec 07].
14. Nigeria: Administrative Division. City Population. Available from: http://www.citypopulation.de/php/nigeria-admin.php. [Last retrieved on 2014 Nov 28].
15. Social Infrastructure. Online Nigeria; October 02, 2003. Available from: https//www.onlinenigeria.com/rivers-state/?blurb=364. [Last
retrieved on 2010 Mar 04].
16. Kola MO, Adeola FA, Lawrence AA, Oluseyi OA. Human papillomavirus vaccine: Knowledge, attitude and perception of parents in Southwest Nigeria. Med Sci Public Health 2013;1:13‑9.
17. Kamzol W, Jaglarz K, Tomaszewski KA, Puskulluoglu M, Krzemieniecki K. Assessment of knowledge about cervical cancer and its prevention among female students aged 17-26 years. Eur J Obstet Gynecol Reprod Biol 2013;166:196‑203.
18. Lenselink CH, Schmeink CE, Melchers WJ, Massuger LF, HendriksJC, van Hamont D, et al. Young adults and acceptance of the human
papillomavirus vaccine. Public Health 2008;122:1295‑301.
19. Iliyasu Z, Abubakar IS, Aliyu MH, Galadanci HS. Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in Northern Nigeria. J Obstet Gynaecol 2010;30:857‑62.
20. Marek E, Dergez T, Rebek‑Nagy G, Kricskovics A, Kovacs K, Bozsa S, et al. Adolescents’ awareness of HPV infections and attitudes towards
HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary. Vaccine 2011;29:8591‑8.
21. Saha A, Chaudhury AN, Bhowmik P, Chatterjee R. Awareness of cervical cancer among female students of premier colleges in Kolkata, India. Asian Pac J Cancer Prev 2010;11:1085‑90.
22. Hopkins TG, Wood N. Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes. Vaccine 2013;31:1673‑9.
23. Perkins RB, Langrish SM, Cotton DJ, Simon CJ. Maternal support for human papillomavirus vaccination in Honduras. J Womens Health (Larchmt) 2011;20:85‑90.
24. Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 2008;42:237‑42.
25. Hoover DR, Carfioli B, Moench EA. Attitudes of adolescent/young adult women towards human papillomavirus vaccination and clinical trials. Health Care Women Int 2000;21:375‑91.
26. Marlow LA, Waller J, Wardle J. Parental attitudes to pre‑pubertal HPV vaccination. Vaccine 2007;25:1945‑52.
27. Hsu YY, Fetzer SJ, Hsu KF, Chang YY, Huang CP, Chou CY, et al. Intention to obtain human papillomavirus vaccination among Taiwanese undergraduate women. Sex Transm Dis 2009;36:686‑92.
28. Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, Lo SS, et al. Acceptability of human papillomavirus vaccination among Chinese women: Concerns and implications. BJOG 2009;116:501‑10.
29. Federal Ministry of Health (Nigeria). National HIV & AIDS and Reproductive Health Survey 2012 (NARHS Plus). FMOH; November, 2013.